Aase-Smith syndrome type 1

Aase-Smith syndrome type 1 (also known as Aase syndrome or Aase-Smith syndrome I) is an extremely rare genetic disorder characterized by the combination of congenital hypoplastic anemia (specifically a triphalangeal thumb-associated anemia resembling Diamond-Blackfan anemia) and skeletal malformations. The condition is present from birth and primarily affects the blood system and the musculoskeletal system. Key clinical features include a hypoplastic or triphalangeal thumb (a thumb with three phalanges instead of the normal two), other skeletal anomalies such as narrow shoulders, and congenital anemia due to reduced red blood cell production in the bone marrow. Some patients may also exhibit mild growth retardation, pale skin due to anemia, and variable craniofacial features. The hematologic component of Aase-Smith syndrome type 1 typically manifests as a red cell aplasia that may improve with age in some cases. Treatment is primarily supportive and may include corticosteroid therapy to stimulate red blood cell production, blood transfusions for severe anemia, and in refractory cases, bone marrow transplantation has been considered. Orthopedic interventions may be necessary for significant skeletal anomalies. Due to the extreme rarity of this condition, management is largely guided by individual clinical presentation and expert opinion rather than large-scale clinical trials. Genetic counseling is recommended for affected families.

Common questions about Aase-Smith syndrome type 1